Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-24 @ 7:47 PM
NCT ID:
NCT00454103
Eligibility Criteria:
Inclusion Criteria:
1. Adrenal tumor seen by CT or MRT-scan with diameter of at least 2 cm or patient with adrenocortical carcinoma and suspected metastasis or local recurrence or patients with primary hyperaldosteronismus and adrenal tumour \> 1 cm
2. Hormonal work up of of the adrenal tumor according to ENS@T (European network for the study of adrenal tumours)-criteria
3. Age ≥ 30 Jahre
4. Effective contraception (pearl index \<1%)
5. Written informed consent
Exclusion Criteria:
1. Pregnancy or breast feeding
2. Renal insufficiency (serum creatinine \> 2,0 mg/dl or MDRD \< 60 ml/min)
3. Known allergy to etomidate or constituents of the test drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT00454103
Study Brief:
Protocol Section:
NCT00454103